NAS:ASND (Denmark) Also Trade In: Germany

Ascendis Pharma A/S $ 139.13 -1.34 (-0.95%)

Volume:
216,784
Avg Vol (1m):
284,105
Market Cap $:
6.64 Bil
Enterprise Value $:
5.96 Bil
P/E (TTM):
0.00
P/B:
9.13
Warning! GuruFocus has detected 2 Severe warning signs with ASND. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for ASND (Ascendis Pharma A/S) from 2015 to Jan 20 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Ascendis Pharma A/S stock (ASND) PE ratio as of Jan 20 2020 is 0. More Details

Ascendis Pharma A/S PE Ratio (TTM) Chart

EMBED

Ascendis Pharma A/S PE Ratio (TTM) Historical Data

Total 1250
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Ascendis Pharma A/S PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2020-01-200.0 2019-11-180.0
2020-01-170.0 2019-11-150.0
2020-01-160.0 2019-11-140.0
2020-01-150.0 2019-11-130.0
2020-01-140.0 2019-11-120.0
2020-01-130.0 2019-11-110.0
2020-01-100.0 2019-11-080.0
2020-01-090.0 2019-11-070.0
2020-01-080.0 2019-11-060.0
2020-01-070.0 2019-11-050.0
2020-01-060.0 2019-11-040.0
2020-01-030.0 2019-11-010.0
2020-01-020.0 2019-10-310.0
2020-01-010.0 2019-10-300.0
2019-12-310.0 2019-10-290.0
2019-12-300.0 2019-10-280.0
2019-12-270.0 2019-10-250.0
2019-12-260.0 2019-10-240.0
2019-12-250.0 2019-10-230.0
2019-12-240.0 2019-10-220.0
2019-12-230.0 2019-10-210.0
2019-12-200.0 2019-10-180.0
2019-12-190.0 2019-10-170.0
2019-12-180.0 2019-10-160.0
2019-12-170.0 2019-10-150.0
2019-12-160.0 2019-10-140.0
2019-12-130.0 2019-10-110.0
2019-12-120.0 2019-10-100.0
2019-12-110.0 2019-10-090.0
2019-12-100.0 2019-10-080.0
2019-12-090.0 2019-10-070.0
2019-12-060.0 2019-10-040.0
2019-12-050.0 2019-10-030.0
2019-12-040.0 2019-10-020.0
2019-12-030.0 2019-10-010.0
2019-12-020.0 2019-09-300.0
2019-11-290.0 2019-09-270.0
2019-11-280.0 2019-09-260.0
2019-11-270.0 2019-09-250.0
2019-11-260.0 2019-09-240.0
2019-11-250.0 2019-09-230.0
2019-11-220.0 2019-09-200.0
2019-11-210.0 2019-09-190.0
2019-11-200.0 2019-09-180.0
2019-11-190.0 2019-09-170.0

Ascendis Pharma A/S PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry Healthcare » Biotechnology » Biotechnology NAICS : 325411 NAICS : 2833
Traded in other countries A71.Germany ASND.USA
Address Tuborg Boulevard 5, Hellerup, DNK, DK-2900
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP etc. It operates mainly in USA, Germany, and Switzerland and derives the majority of its revenue from the US.